TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - VERTEX PHARMACEUTICALS TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - VERTEX PHARMACEUTICALS Share Price
Certificat
DE000SU0TVG6
| Delayed Deutsche Boerse AG 11:41:30 26/06/2024 pm IST | ||
| 1.87 EUR | -1.58% |
|
| Current month | -43.79% | ||
| 1 month | -43.62% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about VERTEX PHARMACEUTICALS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 26/24/26 | 1.87 | -1.58% |
| 25/24/25 | 1.9 | +15.85% |
| 24/24/24 | 1.64 | -24.07% |
| 21/24/21 | 2.16 | +1.41% |
| 20/24/20 | 2.13 | -15.81% |
Delayed Quote Deutsche Boerse AG
Last update June 26, 2024 at 11:41 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | VERTEX PHARMACEUTICALS INCORPORATED |
| Issuer | 
Société Générale
|
| WKN | SU0TVG |
| ISIN | DE000SU0TVG6 |
| Date issued | 17/10/2023 |
| Strike | 490.3 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 11.35 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.52 € |
|---|---|
| Lowest since issue | 0.51 € |
| Spread | 0.06 € |
| Spread % | 3.21% |
Company Profile
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases.
Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).
Sector
-
Ratings for Vertex Pharmaceuticals Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Vertex Pharmaceuticals Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
473.8
USD
Average target price
465.5
USD
Spread / Average Target
-1.75%
- Stock Market
- Certificates
- Certificat
